Proxy Results (Form 8-K)

On August 14, 2026, ENvue Medical, Inc. (the "Company") held a special meeting of stockholders (the "Special Meeting"). The final voting results of the Special Meeting are set forth below. Stockholders voted on the following proposals:

Proposal No. 1: Reverse Stock Split Proposal

The stockholders voted to approve an amendment to the Company's Amended and Restated Certificate of Incorporation, as amended, to effect, at the discretion of the Company's Board of Directors (the "Board") but prior to the one-year anniversary of the Special Meeting, a reverse stock split of all of the outstanding shares of the Company's common stock, at a ratio in the range of 1-for-2 to 1-for-50, with such ratio to be determined by the Board in its discretion and included in a public announcement. The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis):

Proposal No. 2: Adjournment Proposal

The stockholder voted to approve an adjournment of the Special Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event there are not sufficient votes in favor of any one or more of the proposals presented at the Special Meeting (the "Adjournment Proposal"). The votes were as follows (including shares of preferred stock eligible to vote, on an as converted basis):

Although the Adjournment Proposal received sufficient votes to be approved, no motion to adjourn the Special Meeting was made because the adjournment of the Special Meeting was determined not to be necessary or appropriate.

The results reported above are final voting results. No other matters were considered or voted upon at the Special Meeting.